Table 1.
1. Development | |
1.1. Draw AOP blue-print diagram |
|
1.2. Develop individual KER |
|
2. Evaluation and endorsement | |
2.1. Scientific review of KER |
|
2.2.Endorsement of AOP |
|
Abbreviations: AOP, adverse outcome pathway; KE, key event; KER, key event relationship; OECD, Organisation for Economic Co-operation and Development; EAGMST, Extended Advisory Group on Molecular Screening and Toxicogenomics; WPHA, Working Party on Hazard Assessment; WNT, Working Group of National Coordinators of the Test Guidelines program.